Therefore, this study intends to observe the effects of downregulation of SLC35F2 on the sensitivity to chemotherapy in PCa in vivo and in vitro, so as to lay a theoretical foundation for the clinical enhancement of the chemotherapy sensitivity of PCa and other malignant tumors. Here, SLC35F2 is linked to posterior cortical atrophy.